Sponsorluk
What is Leqembi? The first Alzheimer’s treatment approved today in Saudi Arabia
Posted
Saudi Arabia’s SFDA has approved Leqembi (lecanemab), the Kingdom’s first Alzheimer’s treatment. This innovative drug slows disease progression by targeting beta-amyloid plaques, protein clumps that disrupt brain cell communication. Approved for patients with mild symptoms and specific genetic profiles, Leqembi requires careful monitoring to manage side effects, marking a major step forward in Alzheimer’s care through advanced biotechnology.
Site içinde arama yapın
Kategoriler
- National
- International
- Business
- Technology
- Health
- EĞİTİM BİLGİLERİ
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Chess: 'Pressure does not matter' - Divya Deshmukh on MS Dhoni comparisons
Divya Deshmukh, the 19-year-old chess prodigy, clinched the FIDE Women’s World Cup title in...
Ishita Dutta shares health update from hospital bed with son Vaayu
Ishita Dutta revealed a challenging period where both she and her son Vaayu were hospitalised,...
'I had suicidal thoughts': Chahal breaks silence on divorce, mental health battle
Yuzvendra Chahal revealed the emotional distress and mental health challenges he faced during his...
US mortgage rate shift: 30-year home loan eases to 6.72% after Fed decision; housing demand stays weak
US mortgage rates saw a slight dip this week, with the 30-year fixed rate averaging 6.72%, a...